Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031000
Filing Date
2024-08-09
Accepted
2024-08-09 16:30:43
Documents
53
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 693954
2 ex10-1.htm EX-10.1 294899
3 ex31-1.htm EX-31.1 12387
4 ex31-2.htm EX-31.2 13486
5 ex32-1.htm EX-32.1 7890
6 ex32-2.htm EX-32.2 7666
  Complete submission text file 0001493152-24-031000.txt   3423882

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ogen-20240630.xsd EX-101.SCH 25568
8 XBRL CALCULATION FILE ogen-20240630_cal.xml EX-101.CAL 34860
9 XBRL DEFINITION FILE ogen-20240630_def.xml EX-101.DEF 73638
10 XBRL LABEL FILE ogen-20240630_lab.xml EX-101.LAB 226983
11 XBRL PRESENTATION FILE ogen-20240630_pre.xml EX-101.PRE 162952
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 310745
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 241193274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)